It was reported that 30 significantly inhibits eEF2K at concentrations that are relevant both in vitro and in vivo, and this could explain its antiproliferative activity on human glioma cells and blockage of gliomal cells at the G1–S interface [105]. The gene discussed is EEF2K; the disease is glioma.